Congress Presentations
Stay informed about the latest scientific and medical research from Axsome.
American Headache Society (AHS) 2026
Orlando, FL | June 04 - 07, 2026
Symbravo® | Migraine
Symbravo® (MoSEICTM Meloxicam and Rizatriptan) for the Acute Treatment of Migraine: Post-hoc Composite Efficacy and Return to Function Endpoint Analysis from MOMENTUM
Symbravo® | Migraine
Symbravo® (MoSEICTM Meloxicam and Rizatriptan) for the Acute Treatment of Migraine: Post-Hoc Composite Efficacy and Safety Endpoint Analysis of INTERCEPT and MOMENTUM
Symbravo® | Migraine
Symbravo® (MoSEICTM Meloxicam and Rizatriptan) for the Treatment of Migraine: Sustained Pain Relief and Pain Freedom Among 2-Hour Responders in the Phase 3 MOMENTUM and MOVEMENT Trials
Symbravo® | Migraine
Comparative Efficacy of Symbravo® Versus Gepants for Acute Treatment of Migraine: A Network Meta-Analysis
